Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
Related Posts
Chevron profit hit by low crude oil prices and loss from Hess acquisition
Chevron’s net income took a hit due to loss from the company’s acquisition of Hess in mid-July.
Why the wealthy can’t find enough people to manage their money
Global wealth is poised to grow exponentially, with family offices growing in tangent as the ultra-rich look for personalized services to manage their money. But hiring […]
Tesla inks first deal to build China’s largest grid-scale battery power plant
The U.S. company posted on the Chinese social media service Weibo that the project would be the largest of its kind in China when completed.